Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK369796 Dihydrochloride (N-tert-butylisoquine) 是一种抗疟药,可抑制 hERG 钾离子通道复极化,IC50值为 7.5 μM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 567 | 现货 | ||
2 mg | ¥ 832 | 现货 | ||
5 mg | ¥ 1,320 | 现货 | ||
10 mg | ¥ 1,830 | 现货 | ||
25 mg | ¥ 3,320 | 现货 | ||
50 mg | ¥ 4,830 | 现货 | ||
100 mg | ¥ 6,880 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,250 | 现货 |
产品描述 | GSK369796 Dihydrochloride (N-tert-butylisoquine),is an anti-malaria drug candidate. is an affordable and effective antimalarial and inhibits hERG potassium ion channel repolarization(IC50 of 7.5 μM) |
靶点活性 | K+ channel:7.5 μM |
体外活性 | Analysis of antiviral activities indicated that GSK369796 has high anti-DENV activity in the DENV2 replicon expressing cells with EC50 values of 5.06 ± 0.86 μM. The infectivity assays revealed the EC50 values of 3.03 ± 0.35 μM. The mode of action of this compound is through inhibition of autophagy, thereby affecting DENV2 replication. Moreover, this compounds also showed antiviral activity against the rapidly emerging Zika virus (ZIKV) with EC50 values of 2.57 ± 0.09 μM (GSK369796)[1]. |
别名 | N-tert-butylisoquine |
分子量 | 428.78 |
分子式 | C20H24Cl3N3O |
CAS No. | 1010411-21-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 75 mg/mL (174.91 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.3322 mL | 11.661 mL | 23.322 mL | 58.305 mL |
5 mM | 0.4664 mL | 2.3322 mL | 4.6644 mL | 11.661 mL | |
10 mM | 0.2332 mL | 1.1661 mL | 2.3322 mL | 5.8305 mL | |
20 mM | 0.1166 mL | 0.583 mL | 1.1661 mL | 2.9152 mL | |
50 mM | 0.0466 mL | 0.2332 mL | 0.4664 mL | 1.1661 mL | |
100 mM | 0.0233 mL | 0.1166 mL | 0.2332 mL | 0.583 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
GSK369796 Dihydrochloride 1010411-21-8 Membrane transporter/Ion channel Microbiology/Virology Potassium Channel Parasite inhibit GSK 369796 Dihydrochloride Inhibitor N-tert-butylisoquine GSK369796 GSK 369796 GSK-369796 Dihydrochloride GSK-369796 KcsA inhibitor